China NMPA Product Recall - Eclipse Radiotherapy Planning System

Varian Medical Systems, Inc., through its Chinese subsidiary Varian Medical Devices Trading (Beijing) Co., Ltd., initiated a recall event for its Radiotherapy Planning System (Eclipse). This recall, reported to the National Medical Products Administration (NMPA) on June 18, 2010, addresses a critical software anomaly. The identified issue occurs when multiple users simultaneously edit the same record within the system, potentially corrupting the treatment plan or patient treatment records. Although the records remain accessible, their integrity may be compromised. Under the NMPA's regulatory oversight, Varian's required actions primarily involve informing affected users. The company's China Customer Support Center was tasked with distributing an "Emergency Notice on On-site Safety Matters" to relevant Chinese users, emphasizing the potential data damage and reminding them of precautions. Furthermore, Varian communicated an implementation plan and its completion status to these users. This recall pertains to 203 units of the Eclipse system globally, including those imported into China, highlighting the widespread impact of the software anomaly and the company's commitment to ensuring data reliability for radiotherapy planning.